万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>临床神经病学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>神经科学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>精神病学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>药学

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY《国际神经精神药理学杂志》 (官网投稿)

简介
  • 期刊简称INT J NEUROPSYCHOPH
  • 参考译名《国际神经精神药理学杂志》
  • 核心类别 SCIE(2024版), 外文期刊,
  • IF影响因子
  • 自引率2.80%
  • 主要研究方向医学-CLINICAL NEUROLOGY 临床神经病学;NEUROSCIENCES 神经科学;PHARMACOLOGY & PHARMACY 药学;PSYCHIATRY 精神病学

主要研究方向:

等待设置主要研究方向
医学-CLINICAL NEUROLOGY 临床神经病学;NEUROSCIENCES 神经科学;PHARMACOLOGY & PHARMACY 药学;PSYCHIATRY 精神病学

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY《国际神经精神药理学杂志》(月刊). The central focus of the journal is on research that advances understanding&nb...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿

2期刊网址:https://academic.oup.com/ijnp

3投稿网址:http://mc.manuscriptcentral.com/intjnp

4、官网邮箱:graceaa@pitt.edu(主编)

更多编辑邮箱如下。

5、官网电话:

(412) 624 4609(主编)(210) 567-4205(总编)

6期刊刊期:月刊,一年出版12

2021年8月13日星期

                                 

 

期刊编辑邮箱、电话【官网信息】

 

Field Editors

Clinical Neuropsychopharmacology

Michael Thase

Email: thase@mail.med.upenn.edu

 

Preclinical Neuropsychopharmacology

Carla Gambarana

Email: carla.gambarana@unisi.it

 

David Morilak

Email: morilak@uthscsa.edu

 

Neuroimaging

Gitte Moos Knudsen

Email: gitte@nru.dk

 

Molecular Genetics and Therapeutics

David Goldman

Email: davidgoldman@mail.nih.gov

 

Managing Editor

Ann Miller

Telephone: (210) 567-4205

Email: millera5@uthscsa.edu

 

投稿须知【官网信息】

 

Instructions to authors

Please note that this journal is now fully open access and encourages authors to complete their license to publish online. For more information about Open Access licenses and charges, see the “Open Access” section for more information.

The International Journal of Neuropsychopharmacology (IJNP) is the official scientific journal of the Collegium Internationale Neuro-psychopharmacologicum (CINP). IJNP aims to serve as a major forum for the rapid publication and wide dissemination of high quality, influential research in neuropsychopharmacology, in the basic and clinical domains. The central focus of IJNP is on research that (i) advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application, or (ii) provides insights into the biological basis of neuropsychiatric disorders and thereby advances their treatment, pharmacological, stimulation techniques, behavioral. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology, and neuropsychology. Priority is given to original research that is of wide interest and clearly advances the field.

Editorial policies

iThenticate

IJNP uses iThenticate, a plagiarism detection software, to identify manuscripts that contain significant overlap with existing manuscripts already in publication. We are of course aware that oftentimes in Methods sections there is considerable overlap with previously published manuscripts.

Authorship Disclosure Form

All individuals included as authors of papers must have contributed substantially to the scientific process leading up to the writing of the paper. Such contribution includes the conception and design of the project, the performance of experiments and the analysis and interpretation of data. In addition the author should have made a substantial contribution to drafting or critical revision of the manuscript for important intellectual content.

Please note that the Journal now requires that an Authorship Disclosure Form is completed by every author of the manuscript. It is the responsibility of the submitting author to collect the completed forms from all authors and to upload the forms in PDF format via ScholarOne. Papers with missing or incomplete forms will be returned to the author. Therefore, before you start submitting your paper please make sure that you have obtained all the completed forms.

We are aware that authors sometimes receive assistance from technical writers, language editors, and/or writing agencies in preparing manuscripts for publication. Such assistance must be noted in the cover letter and in the Acknowledgements section along with a declaration that the author(s) are entirely responsible for the scientific content of the paper.

Failure to acknowledge assistance from technical writers, language editors, and/or writing agencies in preparing manuscripts for publication in the cover letter and in the Acknowledgements section may lead to disqualification of the paper.

Under no circumstances will IJNP accept submissions by writing or editorial agencies on behalf of authors and there will be no correspondence with writing or editorial agencies regarding submitted or revised manuscripts.

……

更多详情:

https://academic.oup.com/ijnp/pages/General_Instructions


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭